Compensatory Cognitive Training For Schizophrenia

Schizophrenia Clinical Trial

Official title:

Compensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04040998
• Other study ID #: TaoyuanMH
• Status: Completed
• Phase: N/A
• Start date: January 5, 2018
• Est. completion date: May 31, 2018

Study information

• Verified date: July 2019
• Source: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to investigate the effects of compensatory cognitive training plus treatment as usual (CCT+TAU) versus treatment as usual (TAU) on on self-esteem, self-efficacy, quality of life, and self-stigma for schizophrenia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: May 31, 2018
• Est. primary completion date: May 31, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• diagnosis of schizophrenia, based on the ICD-10 diagnostic criteria for research (World Health Organization, 1992)

• age from 20 to 65

• attending day care center regularly for at least 3 months

• taking stable dose of medication for at least 3 months

Exclusion Criteria:

• comorbid autism spectrum disorder

• comorbid mental retardation

• lacking the reading and writing skills

Related Conditions & MeSH terms

• Schizophrenia

Intervention

Behavioral:
• Compensatory Cognitive Training
Teach the participants compensatory cognitive skills and strategies

Locations

Country	Name	City	State
Taiwan	Taoyuan Psychiatric Center Ministry of Health and Welfare	Taoyuan

Sponsors (1)

Lead Sponsor	Collaborator
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change scores of Rosenberg Self-Esteem Scale (RSES)	The Chinese version of Rosenberg Self-Esteem Scale (RSES) was implemented as self-esteem measures. The total score ranged from 10 to 40, with higher scores reflecting higher levels of self-esteem.	3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention
Primary	Change scores of General Self-Efficacy Scale (GSES)	The Chinese version of General Self-Efficacy Scale (GSES) consisted of 10 items, assessing optimistic self-beliefs to cope with a variety of difficult demands in life. The total score ranged from 10 to 40, with higher scores indicating more self-efficacy.	3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention
Primary	Change scores of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)	The Chinese version of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) was administered to measure subjective quality of life. The total scores ranged from 33-165, with higher scores indicating comparatively lower quality of life.	3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention
Primary	Change scores of Internalized Stigma of Mental Illness (ISMIS)	The Chinese version of Internalized Stigma of Mental Illness (ISMIS) consists of 29 items incorporated in five domains: alienation, stereotype endorsement, discrimination experience, social withdrawal, and stigma resistance. The total scores range from 29-116. The higher scores on the ISMIS indicates more severe internalized stigmatization.	3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention